Elanco Animal Health (ELAN) Short-Term Debt issuances (2021 - 2025)
Elanco Animal Health (ELAN) reported Short-Term Debt issuances of $85.0 million for Q2 2025, up 112.5% sequentially from $40.0 million in Q1 2025.
Elanco Animal Health (ELAN) Short-Term Debt issuances (2021 - 2025) Analysis & Trends
Elanco Animal Health (ELAN) has 5 years of Short-Term Debt issuances data on file, last reported at $85.0 million in Q2 2025.
- For the quarter ending Q2 2025, Short-Term Debt issuances changed N/A year-over-year to $85.0 million; the trailing twelve-month figure through Mar 2026 stood at $85.0 million (down 64.58% YoY), and the FY2025 full-year result was $125.0 million, down 50.0% from the prior year.
- Short-Term Debt issuances grew to $85.0 million in Q2 2025, from $40.0 million in the prior quarter.
- In the past five years, Short-Term Debt issuances ranged from a high of $675.0 million in Q2 2022 to a low of -$738.0 million in Q3 2022.
- A 5-year average of $76.7 million and a median of $85.0 million in 2025 frame the typical range for Short-Term Debt issuances.
- Peak annual rise in Short-Term Debt issuances reached 217.46% in 2023, while the deepest fall reached 92.59% in 2023.
- Tracing ELAN's Short-Term Debt issuances over 5 years: stood at $150.0 million in 2021, then plunged by 592.0% to -$738.0 million in 2022, then jumped by 113.14% to $97.0 million in 2023, then dropped by 17.53% to $80.0 million in 2024, then increased by 6.25% to $85.0 million in 2025.
- Business Quant data shows ELAN's Short-Term Debt issuances at $85.0 million in Q2 2025, $40.0 million in Q1 2025, and $80.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 85.00 Mn |
| Jun 30, 2025 | 85.00 Mn |
| Mar 31, 2025 | 40.00 Mn |
| Mar 31, 2025 | 40.00 Mn |
| Dec 31, 2024 | 80.00 Mn |
| Dec 31, 2024 | 80.00 Mn |
| Sep 30, 2024 | 120.00 Mn |
| Sep 30, 2024 | 120.00 Mn |
| Mar 31, 2024 | 50.00 Mn |
| Mar 31, 2024 | 50.00 Mn |
| Dec 31, 2023 | 97.00 Mn |
| Dec 31, 2023 | 97.00 Mn |
| Sep 30, 2023 | 125.00 Mn |
| Sep 30, 2023 | 125.00 Mn |
| Jun 30, 2023 | 50.00 Mn |
| Jun 30, 2023 | 50.00 Mn |
| Mar 31, 2023 | 200.00 Mn |
| Mar 31, 2023 | 200.00 Mn |
| Sep 30, 2022 | -738.00 Mn |
| Sep 30, 2022 | -738.00 Mn |